Articles with public access mandates - Stephanie WilhelmLearn more
Not available anywhere: 8
Evaluation of kinase activity profiling using chemical proteomics
B Ruprecht, J Zecha, S Heinzlmeir, G Medard, S Lemeer, B Kuster
ACS chemical biology 10 (12), 2743-2752, 2015
Mandates: German Research Foundation
Chemoproteomic selectivity profiling of PIKK and PI3K kinase inhibitors
M Reinecke, B Ruprecht, S Poser, S Wiechmann, M Wilhelm, ...
ACS Chemical Biology 14 (4), 655-664, 2019
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
NVP‐BHG712: Effects of regioisomers on the affinity and selectivity toward the EPHrin family
A Tröster, S Heinzlmeir, BT Berger, SL Gande, K Saxena, S Sreeramulu, ...
ChemMedChem 13 (16), 1629-1633, 2018
Mandates: German Research Foundation, Helmholtz Association
Identification of Highly Potent Protein Kinase C‐Related Kinase 1 Inhibitors by Virtual Screening, Binding Free Energy Rescoring, and in vitro Testing
I Slynko, K Schmidtkunz, T Rumpf, S Klaeger, S Heinzlmeir, A Najar, ...
ChemMedChem 11 (18), 2084-2094, 2016
Mandates: German Research Foundation, European Commission
Evaluation of promoter sequences for the secretory production of a Clostridium thermocellum cellulase in Paenibacillus polymyxa
S Heinze, K Zimmermann, C Ludwig, S Heinzlmeir, WH Schwarz, ...
Applied microbiology and biotechnology 102, 10147-10159, 2018
Mandates: Federal Ministry of Education and Research, Germany
Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1)
D Ostrovskyi, T Rumpf, J Eib, A Lumbroso, I Slynko, S Klaeger, ...
Future Medicinal Chemistry 8 (13), 1537-1551, 2016
Mandates: German Research Foundation, European Commission
Selectivity aspects of activity-based (chemical) probes
S Heinzlmeir, S Müller
Drug Discovery Today 27 (2), 519-528, 2022
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo, Genome Canada …
Expression and purification of EPHA2 tyrosine kinase domain for crystallographic and NMR studies
SL Gande, K Saxena, S Sreeramulu, V Linhard, D Kudlinzki, S Heinzlmeir, ...
Chembiochem 17 (23), 2257-2263, 2016
Mandates: German Research Foundation, Helmholtz Association
Available somewhere: 23
The target landscape of clinical kinase drugs
S Klaeger, S Heinzlmeir, M Wilhelm, H Polzer, B Vick, PA Koenig, ...
Science 358 (6367), eaan4368, 2017
Mandates: German Research Foundation, Helmholtz Association, European Commission …
Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS
Y Bian, R Zheng, FP Bayer, C Wong, YC Chang, C Meng, DP Zolg, ...
Nature communications 11 (1), 157, 2020
Mandates: Canadian Institutes of Health Research, Genome Canada, National Natural …
PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
B Adhikari, J Bozilovic, M Diebold, JD Schwarz, J Hofstetter, M Schröder, ...
Nature chemical biology 16 (11), 1179-1188, 2020
Mandates: Genome Canada, German Research Foundation, Wellcome Trust, European …
The formation of a camalexin biosynthetic metabolon
S Mucha, S Heinzlmeir, V Kriechbaumer, B Strickland, C Kirchhelle, ...
The Plant Cell 31 (11), 2697-2710, 2019
Mandates: German Research Foundation, UK Science and Technology Facilities Council
Proteome activity landscapes of tumor cell lines determine drug responses
M Frejno, C Meng, B Ruprecht, T Oellerich, S Scheich, K Kleigrewe, ...
Nature communications 11 (1), 3639, 2020
Mandates: German Research Foundation, European Commission
Pharmacoproteomic characterisation of human colon and rectal cancer
M Frejno, R Zenezini Chiozzi, M Wilhelm, H Koch, R Zheng, S Klaeger, ...
Molecular systems biology 13 (11), 951, 2017
Mandates: UK Medical Research Council
Design, synthesis, and evaluation of WD-repeat-containing protein 5 (WDR5) degraders
A Dölle, B Adhikari, A Krämer, J Weckesser, N Berner, LM Berger, ...
Journal of medicinal chemistry 64 (15), 10682-10710, 2021
Mandates: Genome Canada, German Research Foundation, Wellcome Trust, European …
Dissecting the sequence determinants for dephosphorylation by the catalytic subunits of phosphatases PP1 and PP2A
B Hoermann, T Kokot, D Helm, S Heinzlmeir, JE Chojnacki, T Schubert, ...
Nature Communications 11 (1), 3583, 2020
Mandates: German Research Foundation, European Commission
Decrypting drug actions and protein modifications by dose-and time-resolved proteomics
J Zecha, FP Bayer, S Wiechmann, J Woortman, N Berner, J Müller, ...
Science 380 (6640), 93-101, 2023
Mandates: German Research Foundation, European Commission, Federal Ministry of …
DENEDDYLASE1 Deconjugates NEDD8 from Non-Cullin Protein Substrates in Arabidopsis thaliana
J Mergner, S Heinzlmeir, B Kuster, C Schwechheimer
The Plant Cell 27 (3), 741-753, 2015
Mandates: German Research Foundation
Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib
RC Montenegro, A Howarth, A Ceroni, V Fedele, B Farran, FP Mesquita, ...
Oncotarget 11 (5), 535, 2020
Mandates: Genome Canada, Wellcome Trust
Chemoproteomics‐aided medicinal chemistry for the discovery of EPHA2 inhibitors
S Heinzlmeir, J Lohse, T Treiber, D Kudlinzki, V Linhard, SL Gande, ...
ChemMedChem 12 (12), 999-1011, 2017
Mandates: German Research Foundation
Publication and funding information is determined automatically by a computer program